Research Article
Systemic Immune-Inflammation Index Is a Prognostic Predictor in Patients with Intrahepatic Cholangiocarcinoma Undergoing Liver Transplantation
Table 2
Comparison of characteristics between the high SII group and low SII group of patients with iCCA who underwent LT.
| | Variables | () | () | value |
| | Gender | | | | | Male | 13 (92.9) | 12 (85.7) | | | Female | 1 (7.1) | 2 (14.3) | | | Age (years) | 50.0 (45.3-60.0) | 54 (47.8-59.3) | | | Child-Pugh Class | | | | | A | 4 (28.6) | 3 (21.4) | | | B | 8 (57.1) | 5 (35.7) | | | C | 2 (14.3) | 6 (42.9) | | | BMI | 23.5 (22.4-25.0) | 22.0 (19.9-23.5) | | | MELD score | 10 (7-14) | 12 (8-18) | | | CEA (μg/L) | 2.6 (1.4-4.2) | 8.2 (3.1-19.3) | | | CA19-9 (U/L) | 59.6 (12.0-235.1) | 576.5 (9.2-3874.4) | | | AFP (ng/L) | 3.2 (2.6-5.6) | 4.3 (2.8-5.5) | | | Tumor number | | | | | Single | 10 (71.4) | 9 (64.3) | | | Multiple | 4 (28.6) | 5 (35.7) | | | Largest tumor size (cm) | 2.9 (2.0-7.6) | 6.1 (4.3-7.0) | | | HBsAg | | | | | Positive | 8 (57.1) | 9 (64.3) | | | Negative | 6 (42.9) | 5 (35.7) | | | Pretransplant locoregional therapy | 11 (78.6) | 10 (71.4) | | | Differentiation | | | | | Well | 2 (14.3) | 0 (0.0) | | | Moderate | 8 (57.1) | 10 (71.4) | | | Poor | 4 (28.6) | 4 (28.6) | | | Vascular invasion | 3 (21.4) | 5 (35.7) | | | Tumor recurrence | 6 (42.9) | 9 (64.3) | |
|
|
Data are presented as (%) or median (IQR). |
